Unlock instant, AI-driven research and patent intelligence for your innovation.

Tankyrase inhibitor

A technology of compounds and solvates, applied in the field of tankyrase inhibitors

Active Publication Date: 2017-10-03
BEIJING SIHUAN PHARMA
View PDF2 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] At present, no small-molecule inhibitors targeting tankyrase have entered clinical research, so there is a huge demand for the application of this target in the field of cancer therapy

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Tankyrase inhibitor
  • Tankyrase inhibitor
  • Tankyrase inhibitor

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0091] The preparation of step 1 intermediate 1

[0092] Dissolve raw material 1 and a basic solvent (such as triethylamine) in an organic solvent (such as dichloromethane), lower the temperature (such as -25 to -10°C), add raw material 2, and keep the reaction at low temperature. After the reaction is complete, concentrate to obtain the intermediate 1.

[0093] Step 2 Preparation of intermediate 2

[0094] Intermediate 2 was purchased or prepared by yourself.

[0095] Step 3 Preparation of Intermediate 3

[0096] Dissolve intermediate 1 in a suitable solvent (such as acetonitrile), add intermediate 2 and a basic substance (such as potassium carbonate), react at 60-90°C (for example, 10-20 hours), complete the reaction, concentrate, and purify (such as Silica gel column chromatography) to obtain intermediate 3.

[0097] Step 4 Preparation of Intermediate 4

[0098] Dissolve intermediate 3 in a suitable solvent (such as dichloromethane), add an acid (such as trifluoroaceti...

experiment example 1

[0134] Experimental Example 1 The in vitro enzymatic activity test of the compound of the present invention

[0135] Test product: the compound of the present invention, its chemical name and preparation method are shown in the preparation examples of the compound.

[0136] (1) Preparation of the test product

[0137] Preparation of the 10mM stock solution of the test product: Weigh an appropriate amount of the test product (see the table below for the specific weighing amount), add an appropriate amount of DMSO to dissolve, mix well, and set aside.

[0138] 10 mM stock solution was taken respectively, and diluted with DMSO to a solution with a concentration of 1 mM, which was used as the mother solution. The above mother solution was diluted 10 times with DMSO to make a series of solutions of concentrations, and then diluted 10 times with water to make solutions containing 10% DMSO, the concentrations were: 100 μM, 10 μM, 1 μM, 0.1 μM.

[0139]

[0140] (2) Experimental...

experiment example 2

[0160] Experimental example 2 The effect of the compound of the present invention on the protein of AXIN2 in SW480 cells

[0161] Test product: the compound of the present invention, its chemical name and preparation method are shown in the preparation examples of the compound.

[0162] (1) Preparation of the test product

[0163] Weigh 2.00 mg of compound 1, add an appropriate amount of DMSO to dissolve, and mix well to obtain a 10 mM stock solution of compound 1.

[0164] Take 10mM stock solutions respectively, and dilute the above mother solutions step by step with DMSO to make mother solutions with concentrations of 1mM and 0.2mM (×1000), then dilute them 1000 times with culture medium, and then add them to the corresponding wells of the 6-well plate. The final concentration of the obtained compound solution was: 1 μM, 0.2 μM.

[0165] (2) Experimental method:

[0166] 1. Cell culture: human colorectal cancer cells SW480, using Leibovitz's L-15 medium + 10% FBS + 1% P...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the technical field of medicine and specifically relates to a tankyrase inhibitor represented as a general formula (I) and pharmaceutically acceptable salts, esters, solvated compounds or stereisomers of the tankyrase inhibitor, wherein R1, R2, X1, X2, Y1, Y2, Y3, Y4, Z, L, n and A are defined as in the description. The invention also relates to preparation methods of the compounds, pharmaceutical preparations and pharmaceutical compositions containing the compounds, and applications of the compounds and the pharmaceutically acceptable salts, esters, solvated compounds or the stereoisomers of the compounds in preparing medicines of curing and / or preventing cancers and related diseases which are mediated by tankyrase.

Description

technical field [0001] The invention belongs to the technical field of medicine, and in particular relates to tankyrase inhibitors, or pharmaceutically acceptable salts, esters, solvates and stereoisomers thereof, preparation methods of these compounds, pharmaceutical preparations and medicines containing these compounds Compositions, and the application of these compounds in the preparation of medicines for treating and / or preventing cancer, Alzheimer's disease, osteoporosis, skin diseases, cardiovascular diseases, and type II diabetes. Background technique [0002] As we all know, cancer has become one of the most serious diseases threatening human life and health, and more than nine million people around the world suffer from malignant tumors every year. Therefore, finding effective drugs and methods for the prevention and treatment of cancer has become an urgent task in today's society. Cancer is a disease characterized by loss of proper control of cell growth. Accordi...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07D401/12C07D239/95C07D487/04C07D491/052A61K31/517A61K31/519A61K45/06A61P35/00A61P25/28A61P19/10A61P9/00A61P3/10
CPCC07D239/95C07D401/12C07D487/04C07D491/052
Inventor 吴永谦亓蕖祖超
Owner BEIJING SIHUAN PHARMA